#CancerTherapy
LightNews LightNews
bionewscentral.com
A new strategy targets the #WNTsignaling pathway, whose hyperactivity is common in #cancers and boosts malignancy through multiple mechanisms.
#WNTpathway #CancerTherapy
New strategy may target the WNT signaling pathway to treat cancer with minimal side effect – BioNews Central
A new strategy targets the WNT signaling pathway, whose hyperactivity is common in cancers and boosts malignancy through multiple mechanisms. ...
sbee.link
November 2, 2026 at 6:07 PM
theinnovation.bsky.social
Check out the latest issue of The Innovation Oncology!!! Volume 1, Issue 3 is now online!
#oncology #cancertherapy #oncolyticvirustherapy #cancerscreenings #ColorectalCancer #TumorMicroenvironment #Chemoradiotherapy #immunotherapy #breastcancer #deeplearning #Ferroptosis #PrecisionOncology
October 26, 2026 at 3:46 AM
hulio-ai.bsky.social
🚫 Not general cancer treatment: Never replace main therapies.
🧬 May help select colorectal cancer with key mutations.
⚠️ Bleeding risk: Only use with oncologist advice.
#AspirinInCancer #CancerTherapy #ColorectalCancer #CancerRisks
View in Timelines
October 21, 2026 at 2:01 PM
sigtrans-sttt.bsky.social
Read how dysregulated C-MET signaling contributes to tumor growth and #DrugResistance.

An overview of the structure & mechanisms of C-MET, alongside the current clinical strategies and therapeutic inhibitors for #CancerTherapy.

#STTT #OpenAccess: doi.org/10.1038/s413...
C-MET tyrosine kinase receptor: mechanisms, clinical applications and future perspectives in cancer therapy
October 19, 2026 at 6:00 AM
scienceinboston.com
Congratulations to Dr. Joyce Liu from @danafarber.bsky.social! She is the recipient of the 2026 Michaele C. Christian Oncology Drug Development Award and Lectureship from the National Cancer Institute.

Learn more about her #CancerTherapy work: https://bit.ly/4s6iz7d
October 14, 2026 at 11:05 PM
gmj-georgia.bsky.social
A naturally occurring bacterium from amphibian intestines completely eliminated colorectal tumors in mice with a single dose—by combining di…

#Cancertherapy #Colorectalcancer #Immunotherapy #Microbiome #Preclinicalresearch

#Cancertherapy #Colorectalcancer #Immunotherapy #Microbiome #Preclinical…
Frog bacterium wipes out cancer tumors in mice
A naturally occurring bacterium from amphibian intestines completely eliminated colorectal tumors in mice with a single dose—by combining di… #Cancertherapy #Colorectalcancer #Immunotherapy #Microbiome #Preclinicalresearch
news.gmj.ge
October 10, 2026 at 5:26 PM
sigtrans-sttt.bsky.social
Can anti-BCL2 therapy achieve durable clearance of giant congenital melanocytic nevus?

BCL2 inhibition targets senescent and proliferative cells while inducing neutrophil extracellular traps and T-cell responses.

STTT #OpenAccess: doi.org/10.1038/s413...
#Apoptosis #CancerTherapy
Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction
October 6, 2026 at 3:45 PM
gmj-georgia.bsky.social
A common blood pressure drug is making cancer therapy far more powerful. Telmisartan, prescribed to millions for hypertension, enhances olaparib's anticancer …

#Cancertherapy #Clinicaltrials #Drugrepurposing #Immunotherapy #Olaparib

#Cancertherapy #Clinicaltrials #Drugrepurposing #Immunotherapy…
Blood Pressure Drug Boosts Cancer Treatment
A common blood pressure drug is making cancer therapy far more powerful. Telmisartan, prescribed to millions for hypertension, enhances olaparib's anticancer … #Cancertherapy #Clinicaltrials #Drugrepurposing #Immunotherapy #Olaparib
news.gmj.ge
October 3, 2026 at 3:27 PM
mdpipharma.bsky.social
🎯 Non-toxic #multidrug combos for RCC—rationally designed, hypoxia-enhanced. ODCs show up to 77% efficacy in 2D & 62% in 3D spheroids. Durable responses, no toxicity in organ models.

📌 doi.org/10.3390/phar...
#RCC #DrugCombinations #Hypoxia #CancerTherapy
September 30, 2026 at 9:55 AM
cancers-mdpi.bsky.social
🌟We are delighted to share some highly cited #SpecialIssues in 2025 related to "Cancer Therapy" in Cancers (ISSN 2072-6694)!

🔎Explore them at the link: www.mdpi.com/journal/canc...

#CancerTherapy #Oncology #Management #Surgery
September 28, 2026 at 7:37 AM
cancers-mdpi.bsky.social
🥳We are pleased to announce that Prof. Dr. Tadeusz Robak has been appointed as the Section Editor-in-Chief of "Cancer Therapy"!

📰Check out the short Q&A, including his vision for the journal and views on the research area and open-access publishing: www.mdpi.com/about/announ...

#CancerTherapy
September 28, 2026 at 3:34 AM
bvsspa.bsky.social
🧬 “Non-Canonical, Extralysosomal Activities of Lysosomal Peptidases in Physiological and Pathological Conditions: New Clinical Opportunities for Cancer Therapy” @cabimer.bsky.social.

👉 Disponible en #risalud hdl.handle.net/10668/31552

#BVSSPA #LysosomalPeptidases #CancerTherapy
September 25, 2026 at 6:01 AM
degruyterbrillimms.bsky.social
#AI could make #ProstateCancer drug delivery more precise.
This study combines PSMA-targeted, stimuli-responsive #nanocarriers with interpretable machine learning to predict targeting efficiency and optimize treatment performance.

#NanotechnologyReviews: doi.org/10.1515/ntre...

#CancerTherapy
AI-guided PSMA-targeted stimuli-responsive nanoplatform for precision drug delivery in prostate cancer
September 24, 2026 at 12:15 PM
materchemfront.rsc.org
🔔 Review article by Liyan Yang and Zhonglei Wang

Podophyllotoxin-based intelligent nanoplatforms for augmented tumor therapy: strategies, challenges, and perspectives

🔗 doi.org/10.1039/d6qm...

#Podophyllotoxin #Nanomedicine #CancerTherapy #DrugDelivery
September 22, 2026 at 6:35 AM
mdpipharma.bsky.social
🥇146 citations! #Gold #nanoparticles in #drug delivery—a comprehensive review. Synthesis, shapes, targeting, release mechanisms, cellular uptake & applications across cancer, cardiovascular, ocular & diabetes therapy.

📌 www.mdpi.com/1999-4923/16...
#AuNPs #Nanomedicine #DrugDelivery #CancerTherapy
September 17, 2026 at 10:10 AM
mdpipharma.bsky.social
@microbesinfo.bsky.social

🎯 Carrier-free curcumin NPs + TA/Fe(III) coating = triple therapy for TNBC. Chemo + photothermal + ferroptosis in one nanodrug. High loading, NIR-triggered, 4T1 validated.

📌 www.mdpi.com/1999-4923/17...
#TNBC #Nanomedicine #Ferroptosis #CancerTherapy
September 16, 2026 at 10:12 AM
oopsmyopinion.bsky.social
www.sciencealert.com/a-3-year-old...

#Cancer #cancertherapy #MedicalAdvancements
A 3-Year-Old's Metastatic Cancer Disappeared After Two Doses of Experimental Therapy
A powerful advance in cancer-fighting medicine has achieved an extraordinary new milestone.
www.sciencealert.com
September 15, 2026 at 2:57 PM
currentmedscience.bsky.social
#Computational data clarify how SZKJT activates #Phytochemicals to treat OSCC. This study provides mechanistic insights into phytochemical-based #CancerTherapy. #medsky

Read: doi.org/10.1007/s115...

#currentmedicalscience #Oncology #TranslationalOncology #Phytotherapy #Cancer
Integrative Network Pharmacology and Molecular Docking Analyses on the Mechanisms of San-Zhong-Kui-Jian-Tang in Treating Oral Squamous Cell Carcinoma
September 8, 2026 at 1:03 PM
currentmedscience.bsky.social
Could #NOX4 reshape #ColorectalCancer therapy?

This study shows that NOX4 acts as a #Ferroptosis suppressor and reveals a metabolic vulnerability, spotlighting NOX4 as a therapeutic target. #medsky
Read: doi.org/10.1007/s115...

#currentmedicalscience #Oncology #CancerTherapy
NOX4 Suppresses Ferroptosis Through Regulation of the Pentose Phosphate Pathway in Colorectal Cancer
September 2, 2026 at 3:45 AM
newsen.bsky.social
Karyopharm Therapeutics Grants Stock Options to New Employees Under Nasdaq Rule 5635(c)(4)#USA#Karyopharm#XPOVIO#Newton#CancerTherapy
Karyopharm Therapeutics Grants Stock Options to New Employees Under Nasdaq Rule 5635(c)(4)
Karyopharm Therapeutics has awarded stock units to new hires, enhancing its workforce in innovative cancer therapy development amidst Nasdaq compliance.
third-news.com
September 1, 2026 at 8:14 PM
readbentham.bsky.social
✨ Did you know that nanocarriers can enhance the delivery of herbal bioactive compounds for cancer treatment?

🔗 𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞: https://bit.ly/4xtCbUW

#Nanomedicine #CancerResearch #DrugDelivery #Nanotechnology #HerbalMedicine #CancerTherapy #BenthamScience #DidYouKnow
August 30, 2026 at 4:00 PM
oae-evcna.bsky.social
🚀 Advancing #EV-based #cancertherapy!
We’re delighted to welcome María Sancho Albero from the University of Zaragoza to the EVCNA Junior Editorial Board! 🧬
Her research bridges extracellular vesicles, nanomaterials, targeted delivery and cancer therapy. 🔬🎯
August 28, 2026 at 8:07 AM
degruyterbrillimms.bsky.social
Advancing #CancerTherapy requires stable, efficient drug delivery systems.

This study shows IR780-loaded #micelles enhance anticancer activity while providing high stability and efficient drug delivery for future cancer treatments.

#OpenAccess in #OpenChemistry: doi.org/10.1515/chem...
Near-infrared IR780 dye-loaded poloxamer 407 micelles: Preparation and in vitro assessment of anticancer activity
August 25, 2026 at 7:01 AM
sigtrans-sttt.bsky.social
First-in-class #Oncology drugs are reshaping #CancerTherapy via novel targets, precision strategies & emerging modalities.

This review maps global innovation and highlights challenges limiting their clinical translation. @tsinghuauniversity.bsky.social

#STTT #OpenAccess: doi.org/10.1038/s413...
The evolving global landscape of first-in-class oncology drug innovation
August 24, 2026 at 6:45 AM
sigtrans-sttt.bsky.social
Cancer cells can exploit EMT to acquire invasive, metastatic and therapy-resistant traits. This review details the molecular drivers and cellular plasticity of #EMT and discusses therapeutic strategies targeting this program.

#STTT #OpenAccess: doi.org/10.1038/s413...

#CancerTherapy
Role of epithelial-mesenchymal transition (EMT) in malignancies: current status and future prospects
August 23, 2026 at 3:45 PM